Retroviral gene transfer to primitive normal and leukemic hematopoietic cells using clinically applicable procedures.

P F Hughes; J D Thacker; D Hogge; H J Sutherland; T E Thomas; P M Lansdorp; C J Eaves; R K Humphries

doi:10.1172/JCI115786

Retroviral gene transfer to primitive normal and leukemic hematopoietic cells using clinically applicable procedures.

P F Hughes, J D Thacker, D Hogge, H J Sutherland, T E Thomas, P M Lansdorp, C J Eaves, and R K Humphries

Published June 1, 1992 - More info

View PDF

Abstract

Clinical uses of gene transfer to bone marrow transplants require the establishment of a reproducible method for infecting large numbers of very primitive hematopoietic cells at high efficiency using cell-free retrovirus-containing media. In this study we report the results of experiments with preparations of a high-titer (2-5 x 10(7)/ml) helper-free recombinant neo(r) retrovirus that indicate this goal can now be achieved based on measurements of gene transfer efficiencies to cells referred to as long-term culture initiating cells (LTC-IC) because they give rise to clonogenic cells after greater than or equal to 5 wk in long-term culture (LTC). Intermittent, repeated exposure of normal human marrow mononuclear cells to virus-containing supernatant over a 3-d period of cell maintenance on an IL-3/granulocyte colony-stimulating factor (G-CSF) producing stromal layer resulted in gene transfer efficiencies to LTC-IC of 41%; a level previously obtainable only using co-cultivation infection techniques. Marrow cells enriched greater than or equal to 500-fold for LTC-IC (1-2% pure) by flow cytometry showed gene transfer efficiencies of 27% when infected in a similar fashion over a shorter period (24 h), but in the presence of added soluble IL-3 and G-CSF without stromal feeders, and this increased to 61% when Steel factor was also present during the infection period. By using a less highly enriched population of LTC-IC obtained by a bulk immunoselection technique applicable to large-scale clinical marrow harvests, gene transfer efficiencies to LTC-IC of 40% were achieved and this was increased to 60% by short-term preselection in G418. Southern analysis of DNA from the nonadherent cells produced by these LTC over a 6-wk period provided evidence of clonal evolution of LTC-IC in vitro. Leukemic chronic myelogenous leukemia LTC-IC were also infected at high efficiency using the same supernatant infection strategy with growth factor supplementation. These data demonstrate the feasibility of using cell-free virus preparations for infecting clinical marrow samples suitable for transplantation, as well as for further analysis of human marrow stem cell dynamics in vitro.

Images.

Retroviral gene transfer to primitive normal and leukemic hematopoietic cells using clinically applicable procedures.

P F Hughes, J D Thacker, D Hogge, H J Sutherland, T E Thomas, P M Lansdorp, C J Eaves, and R K Humphries

Article tools

Metrics

Go to

Retroviral gene transfer to primitive normal and leukemic hematopoietic cells using clinically applicable procedures.

P F Hughes, J D Thacker, D Hogge, H J Sutherland, T E Thomas, P M Lansdorp, C J Eaves, and R K Humphries

Article tools

Metrics

Go to

Sign up for email alerts